Rapidly Progressive and Catastrophic Calciphylaxis After Mechanical Valve Replacement: An Anticoagulation Dilemma

Philippe F. Nyembo, Keith E. Eidman, Mengistu Simegn, Andrew W. Shaffer, Gautam R. Shroff

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Warfarin is the only approved anticoagulant after mechanical valve replacement, but it is a well described risk factor for calciphylaxis among patients with end-stage kidney disease. Our patient with end-stage kidney disease rapidly developed calciphylaxis after dual mechanical valve replacement in association with warfarin initiation, posing significant challenges in clinical management and a fatal outcome. (Level of Difficulty: Intermediate.)

Original languageEnglish (US)
Pages (from-to)1319-1323
Number of pages5
JournalJACC: Case Reports
Volume4
Issue number19
DOIs
StatePublished - Oct 5 2022

Bibliographical note

Publisher Copyright:
© 2022 The Authors

Keywords

  • anticoagulation
  • disorders of calcium disease
  • thrombosis
  • valve replacement

PubMed: MeSH publication types

  • Case Reports

Fingerprint

Dive into the research topics of 'Rapidly Progressive and Catastrophic Calciphylaxis After Mechanical Valve Replacement: An Anticoagulation Dilemma'. Together they form a unique fingerprint.

Cite this